BIO-Key International Inc

BIO-Key International Inc(BKYI)資訊與事件

$3.075

-0.025 (-0.81%)收盤時

BKYI 資訊

BKYI 事件

8/10 05:30

BIO-key and Visualforma Awarded New Contract by Portuguese National Security Agency

BIO-key announced that, together with its strategic Portuguese partner Visualforma, it has been awarded a new contract to strengthen digital identity security for a Portuguese national security agency. The award is a significant expansion of BIO-key's and Visualforma's long-standing collaboration within the Portuguese public sector. The solution combines centralized identity management with multiple authentication methods.

7/28 05:30

BIO-key Partners with Central Bank of Jordan to Modernize Authentication

BIO-key announced that the Central Bank of Jordan, or CBJ, is working with BIO-key on a national initiative to modernize how end clients authenticate across Jordan's financial sector, which serves a total population of 11.6M. The CBJ initiative reflects a broader move toward biometric-first authentication, with the objective of reducing and ultimately eliminating end-client dependency on passwords, tokens and other traditional credentials and their related costs.

5/12 17:00

BIO-key International Stock to Be Suspended on Nasdaq

BIO-key International announced that it has received written notification from The Nasdaq Stock Market LLC that the trading of its common stock will be suspended on Nasdaq effective with the markets' close today, May 12. BIO-key has received approval from OTC Markets Group for its common stock to be quoted on the OTC Market under the same symbol commencing May 13. "Through shareholder support and our concerted efforts to regain compliance with Nasdaq's continued listing standards via a reverse split, we have restored our share price to a level well in excess of Nasdaq's $1 minimum closing bid price requirement. Unfortunately, due to the timing of the reverse split, we were unable to maintain this share price level for the previous 10 trading days and our listing currently has been suspended," said Michael DePasquale, chairman and CEO. "We are undertaking corrective measures to regain compliance, including retaining expert listing consultants to assist us in this process. With their guidance, we are taking steps that we believe provide us the best opportunity to have trading resume on Nasdaq expeditiously".

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始